For research and educational purposes only. Not medical advice.
Lanreotide Reference
Educational, not medical advice reference for Lanreotide: Hormonal; regulatory status, evidence posture, source review, and schedule notes. Also…
Reference summary
Lanreotide is a label-verified somatostatin analog with decades of approved-label evidence. pepSmart surfaces label-reference content only.
Regulatory and posture
- Categories
- Hormonal
- Aliases
- Somatuline Depot, Somatostatin analog
- Evidence posture
- human
- Regulatory status
- FDA-approved prescription medication (Somatuline Depot). Labeled for long-term treatment of acromegaly and for unresectable, well- or moderately-differentiated, locally advanced or metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
- Content review status
- label verified
Selected public sources
Related tools
- Injection-site rotation overview - Public overview of the Pro site-rotation planner.